Skip to main content
Figure 1 | BMC Infectious Diseases

Figure 1

From: Erythropoietin rs1617640 G allele associates with an attenuated rise of serum erythropoietin and a marked decline of hemoglobin in hepatitis C patients undergoing antiviral therapy

Figure 1

Pre- and on-treatment serum EPO levels with regard to EPO rs1617640 genotypes. Pretreatment serum EPO concentrations were equally distributed among major T allele carriers and minor G homozygotes. On-treatment serum EPO concentrations of EPO rs1617640 G homozygotes and T allele carriers at week 4 and 8 of therapy, however, differed significantly in a linear model. Data on serum EPO concentrations were available in 181, 112 and 78 individuals at week 0, 4 and 8, respectively. Medians and IQRs are given.

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us